Nifty

:

25461.00

Sensex

:

83432.89

55.70 (0.22%)
193.42 (0.23%)

Login

Nifty
Sensex

:
:

25461.00
83432.89

55.70 (0.22%)
193.42 (0.23%)

Lyka Labs Ltd.

Pharmaceuticals & Drugs

Rating :

55/99

BSE: 500259 | NSE: LYKALABS

Watchlist

NSE BSE

113.83

04-Jul-2025

Open
High
Low
Previous Close

114.11
114.42
111.33
114.06

Volume
Traded Value (lacs)
52 Week High
52 Week Low

31948
3623701.6
176.59
96.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

405.08
50.56
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

441.66
N/A
3.91

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
12.58
-16.95

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-31.10

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-47.18
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

4.57
9.75
16.20

EV:EBITDA (Average)

8 Years
5 Years
3 Years

100.65
10.41
22.23

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 30.52 26.98 13.12% 32.92 31.41 4.81% 41.16 26.76 53.81% 30.11 21.24 41.76%
Expenses 27.11 24.77 9.45% 27.84 25.56 8.92% 35.81 22.82 56.92% 26.05 18.68 39.45%
EBITDA 3.41 2.21 54.30% 5.09 5.85 -12.99% 5.34 3.94 35.53% 4.05 2.56 58.20%
EBIDTM 11.17% 8.21% 15.45% 18.63% 12.98% 14.71% 13.47% 12.04%
Other Income 0.72 0.39 84.62% 0.87 0.53 64.15% 0.13 0.30 -56.67% 0.62 0.43 44.19%
Interest 0.52 1.03 -49.51% 0.62 1.26 -50.79% 0.52 1.17 -55.56% 0.65 1.33 -51.13%
Depreciation 1.34 2.77 -51.62% 1.75 2.72 -35.66% 1.68 3.46 -51.45% 1.68 3.34 -49.70%
PBT 2.27 -1.21 - 3.59 2.40 49.58% 3.27 -0.44 - 2.35 -1.68 -
Tax 0.97 0.41 136.59% 0.89 1.04 -14.42% 0.80 -0.15 - 0.60 0.04 1,400.00%
PAT 1.31 -1.62 - 2.70 1.36 98.53% 2.47 -0.29 - 1.75 -1.72 -
PATM 4.28% -6.01% 8.20% 4.34% 6.01% -1.09% 5.81% -8.10%
EPS 0.37 -0.45 - 0.76 0.38 100.00% 0.69 -0.08 - 0.49 -0.48 -

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 33.43 27.77 20.38% 33.80 32.56 3.81% 41.16 27.99 47.05% 30.11 22.88 31.60%
Expenses 29.34 25.74 13.99% 28.60 25.70 11.28% 36.20 23.81 52.04% 26.41 20.23 30.55%
EBITDA 4.08 2.03 100.99% 5.19 6.86 -24.34% 4.95 4.18 18.42% 3.71 2.64 40.53%
EBIDTM 12.22% 7.31% 15.37% 21.08% 12.03% 14.94% 12.31% 11.56%
Other Income 0.82 0.29 182.76% 0.83 0.54 53.70% 0.03 0.25 -88.00% 0.56 0.38 47.37%
Interest 0.47 1.07 -56.07% 0.61 1.28 -52.34% 0.54 1.19 -54.62% 0.65 1.35 -51.85%
Depreciation 1.42 2.90 -51.03% 1.83 2.84 -35.56% 1.76 3.60 -51.11% 1.76 3.47 -49.28%
PBT 3.02 -1.63 - 3.57 3.29 8.51% 2.67 -0.79 - 1.86 -1.80 -
Tax 0.99 0.46 115.22% 0.87 1.27 -31.50% 0.76 -0.18 - 0.57 0.13 338.46%
PAT 2.03 -2.09 - 2.71 2.01 34.83% 1.91 -0.62 - 1.29 -1.93 -
PATM 6.07% -7.52% 8.00% 6.18% 4.65% -2.20% 4.28% -8.44%
EPS 0.50 -0.60 - 0.76 0.54 40.74% 0.59 -0.15 - 0.40 -0.56 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Net Sales 134.71 106.40 80.59 164.35 62.26 40.74 41.18 41.68 78.01 57.27 90.48 Net Sales Growth 26.62% 32.03% -50.96% 163.97% 52.82% -1.07% -1.20% -46.57% 36.21% -36.70% Cost Of Goods Sold 53.23 42.94 29.06 30.87 23.52 21.02 22.24 21.53 36.31 34.22 50.81 Gross Profit 81.48 63.45 51.53 133.49 38.74 19.73 18.94 20.15 41.70 23.06 39.67 GP Margin 60.48% 59.63% 63.94% 81.22% 62.22% 48.43% 45.99% 48.34% 53.45% 40.27% 43.84% Total Expenditure 116.81 91.84 64.99 66.85 47.84 43.96 40.27 42.20 56.24 49.67 70.87 Power & Fuel Cost - 3.92 3.57 3.88 2.91 2.52 2.22 1.80 1.84 1.32 1.99 % Of Sales - 3.68% 4.43% 2.36% 4.67% 6.19% 5.39% 4.32% 2.36% 2.30% 2.20% Employee Cost - 26.01 17.48 16.22 13.03 11.71 9.99 10.90 9.99 6.58 9.64 % Of Sales - 24.45% 21.69% 9.87% 20.93% 28.74% 24.26% 26.15% 12.81% 11.49% 10.65% Manufacturing Exp. - 4.49 5.04 4.13 2.89 1.70 1.27 1.06 1.20 0.80 1.39 % Of Sales - 4.22% 6.25% 2.51% 4.64% 4.17% 3.08% 2.54% 1.54% 1.40% 1.54% General & Admin Exp. - 8.79 7.11 5.62 3.78 4.30 3.86 3.40 2.76 2.40 2.61 % Of Sales - 8.26% 8.82% 3.42% 6.07% 10.55% 9.37% 8.16% 3.54% 4.19% 2.88% Selling & Distn. Exp. - 4.48 1.84 4.54 1.23 0.84 0.07 0.15 0.36 0.47 0.86 % Of Sales - 4.21% 2.28% 2.76% 1.98% 2.06% 0.17% 0.36% 0.46% 0.82% 0.95% Miscellaneous Exp. - 1.20 0.89 1.60 0.48 1.88 0.61 3.35 3.77 3.89 0.86 % Of Sales - 1.13% 1.10% 0.97% 0.77% 4.61% 1.48% 8.04% 4.83% 6.79% 3.93% EBITDA 17.89 14.56 15.60 97.50 14.42 -3.22 0.91 -0.52 21.77 7.60 19.61 EBITDA Margin 13.28% 13.68% 19.36% 59.32% 23.16% -7.90% 2.21% -1.25% 27.91% 13.27% 21.67% Other Income 2.34 1.65 3.45 2.72 2.21 2.60 2.66 1.89 1.71 11.93 1.71 Interest 2.31 4.80 11.57 19.92 25.55 19.01 5.73 7.76 16.54 12.68 19.76 Depreciation 6.45 12.29 13.52 15.39 8.05 7.77 4.44 6.31 5.53 2.64 3.83 PBT 11.48 -0.88 -6.03 64.91 -16.97 -27.40 -6.59 -12.69 1.41 4.22 -2.27 Tax 3.26 1.34 0.08 20.34 -3.94 0.24 -8.83 -0.38 -0.37 0.00 0.00 Tax Rate 28.40% -142.55% -0.61% 33.76% 21.41% -0.44% 124.37% 3.39% 67.27% 0.00% 0.00% PAT 8.23 -2.27 -13.29 39.90 -14.46 -55.39 1.73 -10.84 -0.19 4.82 1.37 PAT before Minority Interest 8.23 -2.27 -13.29 39.90 -14.46 -55.39 1.73 -10.84 -0.19 4.82 1.37 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.11% -2.13% -16.49% 24.28% -23.23% -135.96% 4.20% -26.01% -0.24% 8.42% 1.51% PAT Growth 462.56% - - - - - - - - 251.82% EPS 2.31 -0.64 -3.72 11.18 -4.05 -15.52 0.48 -3.04 -0.05 1.35 0.38

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Net Sales 138.50 111.19 93.07 194.08 86.25 61.49 70.78 59.81 110.08 130.41 166.27 Net Sales Growth 24.55% 19.47% -52.05% 125.02% 40.27% -13.13% 18.34% -45.67% -15.59% -21.57% Cost Of Goods Sold 55.59 44.85 37.55 52.97 37.97 35.79 39.25 29.38 53.85 70.43 90.74 Gross Profit 82.91 66.34 55.52 141.11 48.28 25.70 31.54 30.43 56.23 59.98 75.53 GP Margin 59.86% 59.66% 59.65% 72.71% 55.98% 41.80% 44.56% 50.88% 51.08% 45.99% 45.43% Total Expenditure 120.55 95.48 76.23 92.94 66.57 65.16 72.68 63.36 87.31 110.25 137.62 Power & Fuel Cost - 3.93 3.60 3.92 2.94 2.56 2.28 1.86 1.90 1.39 2.06 % Of Sales - 3.53% 3.87% 2.02% 3.41% 4.16% 3.22% 3.11% 1.73% 1.07% 1.24% Employee Cost - 26.77 18.61 18.06 14.57 13.86 14.69 16.98 17.24 14.71 17.26 % Of Sales - 24.08% 20.00% 9.31% 16.89% 22.54% 20.75% 28.39% 15.66% 11.28% 10.38% Manufacturing Exp. - 4.52 5.09 4.20 3.00 1.73 1.32 1.06 1.20 1.24 1.93 % Of Sales - 4.07% 5.47% 2.16% 3.48% 2.81% 1.86% 1.77% 1.09% 0.95% 1.16% General & Admin Exp. - 9.39 7.89 6.29 4.31 5.70 5.91 5.81 5.96 6.62 7.42 % Of Sales - 8.45% 8.48% 3.24% 5.00% 9.27% 8.35% 9.71% 5.41% 5.08% 4.46% Selling & Distn. Exp. - 4.70 2.59 5.75 2.65 2.27 5.17 2.95 0.37 8.61 13.20 % Of Sales - 4.23% 2.78% 2.96% 3.07% 3.69% 7.30% 4.93% 0.34% 6.60% 7.94% Miscellaneous Exp. - 1.33 0.90 1.74 1.14 3.24 4.07 5.31 6.80 7.25 13.20 % Of Sales - 1.20% 0.97% 0.90% 1.32% 5.27% 5.75% 8.88% 6.18% 5.56% 3.01% EBITDA 17.93 15.71 16.84 101.14 19.68 -3.67 -1.90 -3.55 22.77 20.16 28.65 EBITDA Margin 12.95% 14.13% 18.09% 52.11% 22.82% -5.97% -2.68% -5.94% 20.68% 15.46% 17.23% Other Income 2.24 1.45 3.40 2.09 1.56 3.09 2.09 2.13 2.24 2.06 2.35 Interest 2.27 4.89 11.87 20.13 25.94 20.07 7.17 9.58 18.72 16.42 25.57 Depreciation 6.77 12.80 14.15 17.35 8.32 8.01 7.31 11.28 10.25 9.32 10.87 PBT 11.12 -0.52 -5.78 65.77 -13.02 -28.66 -14.29 -22.28 -3.97 -3.52 -5.44 Tax 3.19 1.69 -0.02 20.80 -4.05 0.74 -9.07 -1.04 -1.51 -0.19 1.06 Tax Rate 28.69% -181.72% 0.15% 35.11% 28.62% -1.20% 58.78% 5.19% 18.62% -4.86% -28.96% PAT 7.94 -2.49 -13.21 39.00 -11.55 -60.54 -5.55 -17.21 -5.54 3.69 -4.95 PAT before Minority Interest 8.02 -2.62 -13.15 38.44 -10.09 -62.62 -6.35 -19.00 -6.60 4.09 -4.72 Minority Interest 0.08 0.13 -0.06 0.56 -1.46 2.08 0.80 1.79 1.06 -0.40 -0.23 PAT Margin 5.73% -2.24% -14.19% 20.09% -13.39% -98.46% -7.84% -28.77% -5.03% 2.83% -2.98% PAT Growth 401.90% - - - - - - - - - EPS 2.22 -0.70 -3.70 10.92 -3.24 -16.96 -1.55 -4.82 -1.55 1.03 -1.39

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Shareholder's Funds 99.33 76.43 44.44 4.41 18.78 98.60 96.78 73.61 66.50 61.16 Share Capital 33.09 30.69 28.69 28.69 28.69 28.14 28.14 22.04 23.13 22.67 Total Reserves 57.17 28.30 15.75 -24.28 -9.91 69.71 67.89 51.57 43.38 38.18 Non-Current Liabilities 50.78 72.46 70.40 147.35 134.87 71.56 6.17 36.77 27.48 32.27 Secured Loans 7.18 0.00 0.00 150.35 125.05 77.90 3.84 34.64 25.27 28.73 Unsecured Loans 35.73 63.40 61.63 0.71 0.64 0.90 0.87 0.84 0.00 0.00 Long Term Provisions 1.74 2.13 2.44 2.68 2.83 2.77 2.54 2.20 2.07 3.05 Current Liabilities 35.78 29.97 93.68 45.39 55.34 68.29 140.46 131.37 134.04 139.68 Trade Payables 10.91 8.23 8.68 12.02 16.50 22.10 21.34 28.11 30.24 39.41 Other Current Liabilities 11.77 12.93 64.08 21.66 26.33 32.27 81.91 64.47 56.66 63.75 Short Term Borrowings 11.61 7.64 19.90 10.09 10.59 12.41 35.59 37.67 46.24 36.07 Short Term Provisions 1.49 1.17 1.02 1.62 1.91 1.51 1.62 1.13 0.90 0.45 Total Liabilities 185.89 178.86 208.52 197.15 208.99 238.45 243.41 241.75 228.02 233.11 Net Block 55.64 65.53 90.11 95.34 101.65 76.23 81.16 86.27 60.26 61.67 Gross Block 156.00 153.59 171.88 162.94 140.52 93.40 94.27 92.84 99.84 98.29 Accumulated Depreciation 100.36 88.07 81.76 67.60 38.87 17.17 13.11 6.58 39.58 36.63 Non Current Assets 136.02 136.56 161.32 171.41 178.29 189.43 190.17 193.96 169.30 169.28 Capital Work in Progress 23.05 16.23 17.74 24.40 26.40 29.71 26.43 24.23 30.17 27.03 Non Current Investment 32.40 32.40 32.40 32.40 32.40 62.45 62.45 62.45 62.57 62.57 Long Term Loans & Adv. 24.92 22.41 21.06 19.28 17.83 21.03 20.12 21.01 16.30 18.02 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 49.86 42.30 47.19 25.73 30.70 49.03 53.24 47.79 58.73 63.84 Current Investments 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 Inventories 9.56 6.94 8.18 4.30 5.71 5.95 7.30 9.25 6.96 12.56 Sundry Debtors 25.73 17.16 17.59 9.90 6.59 29.68 30.26 24.22 26.45 28.83 Cash & Bank 5.89 8.70 15.38 6.53 8.40 0.09 0.47 1.46 1.73 1.70 Other Current Assets 8.68 2.32 2.21 2.42 9.99 13.31 15.22 12.86 23.59 20.74 Short Term Loans & Adv. 5.92 7.17 3.82 2.58 5.77 6.62 14.91 11.29 19.92 17.46 Net Current Assets 14.09 12.33 -46.48 -19.66 -24.64 -19.26 -87.22 -83.57 -75.31 -75.84 Total Assets 185.88 178.86 208.51 197.14 208.99 238.46 243.41 241.75 228.03 233.12

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Shareholder's Funds 68.15 45.44 13.34 -25.80 -14.34 43.02 49.47 37.71 45.24 43.06 Share Capital 33.09 30.69 28.69 28.69 28.69 28.14 28.14 22.04 23.13 22.67 Total Reserves 26.00 -2.69 -15.35 -54.49 -43.03 14.12 20.57 15.67 22.11 20.07 Non-Current Liabilities 50.82 73.25 72.77 148.88 136.67 72.28 5.28 38.68 28.52 36.95 Secured Loans 7.18 0.39 0.86 150.65 125.45 78.39 4.06 34.93 25.31 28.92 Unsecured Loans 35.73 63.40 61.63 0.71 0.64 0.90 0.87 0.84 0.00 0.00 Long Term Provisions 1.82 2.44 3.47 3.66 3.86 4.08 3.63 4.39 2.92 4.30 Current Liabilities 37.64 32.60 99.35 49.88 66.32 84.81 167.12 165.45 162.83 195.24 Trade Payables 12.10 9.41 12.00 14.71 18.85 23.23 24.21 39.16 42.08 54.64 Other Current Liabilities 12.41 14.35 66.24 23.10 30.83 43.31 92.38 73.07 56.55 79.41 Short Term Borrowings 11.61 7.64 20.07 10.37 14.41 16.26 45.82 50.23 59.95 59.85 Short Term Provisions 1.52 1.20 1.05 1.70 2.23 2.02 4.72 2.99 4.26 1.35 Total Liabilities 156.72 151.52 185.61 173.66 187.88 202.85 225.23 248.87 240.50 278.76 Net Block 57.70 68.10 93.96 98.19 104.78 107.73 116.04 132.90 104.23 121.64 Gross Block 160.37 157.96 177.35 202.50 188.36 202.81 155.31 144.01 200.41 213.51 Accumulated Depreciation 102.67 89.87 83.40 104.31 83.58 95.08 39.27 11.11 96.18 91.87 Non Current Assets 106.07 107.32 133.42 144.59 152.00 167.75 176.16 186.07 158.70 177.08 Capital Work in Progress 23.05 16.23 17.74 25.76 27.76 31.07 27.88 24.23 30.17 27.03 Non Current Investment 0.07 0.04 0.01 0.01 0.01 0.01 0.23 0.26 0.39 0.32 Long Term Loans & Adv. 25.25 22.96 21.71 20.63 19.46 28.94 32.01 28.69 23.92 28.09 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 50.65 44.20 52.20 29.08 35.88 35.11 49.07 62.79 81.81 101.69 Current Investments 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 Inventories 9.57 6.95 8.20 4.31 6.73 7.00 11.20 13.24 10.81 19.25 Sundry Debtors 26.99 20.13 18.45 8.67 8.04 14.63 20.50 29.17 43.29 56.70 Cash & Bank 5.95 11.71 17.05 7.15 10.30 1.71 2.43 5.12 5.56 6.51 Other Current Assets 8.12 2.93 2.87 4.73 10.80 11.77 14.95 15.25 22.14 19.23 Short Term Loans & Adv. 4.78 2.48 5.62 4.21 4.26 9.64 13.21 10.92 17.22 14.57 Net Current Assets 13.01 11.61 -47.15 -20.80 -30.44 -49.70 -118.05 -102.66 -81.03 -93.55 Total Assets 156.72 151.52 185.62 173.67 187.88 202.86 225.23 248.86 240.51 278.77

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Cash From Operating Activity 3.09 6.87 76.53 5.75 -11.45 18.31 6.84 20.17 7.70 29.08 PBT -0.93 -13.21 60.24 -18.40 -55.15 -7.10 -11.22 -0.56 4.82 1.37 Adjustment 16.66 31.31 37.60 33.97 54.79 10.34 11.81 22.16 3.29 17.53 Changes in Working Capital -11.16 -10.81 -20.76 -9.10 -11.85 15.30 6.69 -0.29 -0.22 10.28 Cash after chg. in Working capital 4.56 7.29 77.08 6.47 -12.22 18.53 7.28 21.31 7.89 29.17 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.47 -0.41 -0.55 -0.72 0.77 -0.22 -0.44 -1.20 -0.07 -0.83 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 -0.11 0.74 Cash From Investing Activity -8.61 6.77 -4.33 0.13 0.13 -2.94 -3.35 -5.25 5.46 28.74 Net Fixed Assets -9.23 19.80 -2.28 -20.42 -43.81 -2.41 -3.63 12.94 -4.69 29.40 Net Investments -0.01 0.00 0.00 0.00 30.05 -0.01 0.00 0.12 0.00 -0.04 Others 0.63 -13.03 -2.05 20.55 13.89 -0.52 0.28 -18.31 10.15 -0.62 Cash from Financing Activity 2.71 -20.33 -63.35 -7.75 19.61 -15.76 -4.48 -15.20 -13.13 -62.62 Net Cash Inflow / Outflow -2.81 -6.69 8.85 -1.88 8.28 -0.38 -0.99 -0.28 0.03 -4.81 Opening Cash & Equivalents 8.70 15.38 6.53 8.40 0.12 0.47 1.46 1.73 1.70 6.51 Closing Cash & Equivalent 5.89 8.70 15.38 6.53 8.40 0.09 0.47 1.46 1.73 1.70

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Cash From Operating Activity 1.77 8.95 79.25 8.81 5.32 26.67 10.88 31.38 11.95 26.54 PBT -0.93 -13.17 59.25 -14.14 -61.88 -15.42 -20.04 -8.10 3.69 -4.95 Adjustment 18.02 31.78 41.93 35.40 55.76 15.17 20.79 30.53 16.15 31.64 Changes in Working Capital -13.80 -9.86 -21.01 -11.64 10.94 27.65 10.36 10.10 -7.57 -0.79 Cash after chg. in Working capital 3.29 8.75 80.16 9.62 4.82 27.39 11.10 32.53 12.27 25.90 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.52 0.20 -0.92 -0.81 0.50 -1.10 -0.44 -1.20 -0.33 -0.10 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.37 0.23 0.06 0.00 0.74 Cash From Investing Activity -9.49 7.35 -6.17 -0.16 -0.11 -3.97 -3.17 -12.67 17.29 28.99 Net Fixed Assets -9.23 19.80 -2.28 -20.42 -43.81 -2.41 -3.63 12.94 -4.69 29.40 Net Investments -0.01 0.00 0.00 0.00 30.05 -0.01 0.00 0.12 0.00 -0.04 Others -0.25 -12.45 -3.89 20.26 13.65 -1.55 0.46 -25.73 21.98 -0.37 Cash from Financing Activity 1.95 -21.64 -63.18 -11.80 3.38 -23.42 -10.41 -19.15 -30.19 -59.72 Net Cash Inflow / Outflow -5.76 -5.34 9.90 -3.15 8.60 -0.72 -2.69 -0.43 -0.96 -4.20 Opening Cash & Equivalents 11.71 17.05 7.15 10.30 1.71 2.43 5.12 5.56 6.51 10.71 Closing Cash & Equivalent 5.95 11.71 17.05 7.15 10.30 1.70 2.43 5.12 5.56 6.51

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Book Value (Rs.) 27.28 19.22 15.49 1.54 6.55 34.77 34.12 33.40 28.49 26.27 ROA -1.24% -6.86% 19.67% -7.12% -24.76% 0.72% -4.47% -0.08% 2.09% 0.55% ROE -3.04% -25.69% 163.37% -124.71% -94.98% 1.79% -12.78% -0.27% 8.07% 2.38% ROCE 2.54% -1.02% 47.25% 4.45% -20.89% -0.70% -1.80% 9.01% 10.47% 11.62% Fixed Asset Turnover 0.69 0.50 0.98 0.41 0.35 0.44 0.45 0.88 0.61 0.83 Receivable days 73.57 78.69 30.52 48.35 162.49 265.62 233.98 108.50 166.05 102.46 Inventory Days 28.30 34.25 13.86 29.33 52.19 58.69 71.09 34.72 58.64 40.00 Payable days 81.33 106.20 122.42 221.30 152.63 195.00 214.53 192.84 278.75 197.37 Cash Conversion Cycle 20.54 6.74 -78.04 -143.63 62.05 129.31 90.54 -49.62 -54.06 -54.91 Total Debt/Equity 0.63 1.21 2.90 36.68 7.29 0.94 1.06 1.53 1.64 1.86 Interest Cover 0.81 -0.14 4.02 0.28 -1.90 -0.24 -0.45 0.97 1.38 1.07

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Book Value (Rs.) 17.86 9.12 4.65 -8.99 -5.00 15.02 16.78 15.82 16.94 14.99 ROA -1.70% -7.80% 21.40% -5.58% -32.05% -2.97% -8.02% -2.70% 1.58% -1.55% ROE -6.02% -63.63% 0.00% 0.00% -448.65% -14.20% -46.30% -18.27% 11.74% -13.05% ROCE 3.26% -1.00% 56.68% 8.95% -31.39% -5.50% -6.52% 6.66% 12.41% 11.73% Fixed Asset Turnover 0.70 0.56 1.02 0.44 0.31 0.40 0.41 0.68 0.65 0.75 Receivable days 77.33 75.65 25.51 35.37 67.29 90.56 149.54 113.31 136.29 132.10 Inventory Days 27.12 29.71 11.76 23.36 40.77 46.92 73.58 37.61 40.97 37.15 Payable days 87.52 104.00 92.01 161.35 117.58 127.84 181.43 174.53 168.94 158.77 Cash Conversion Cycle 16.94 1.36 -54.74 -102.62 -9.53 9.65 41.69 -23.60 8.32 10.48 Total Debt/Equity 0.96 2.58 9.76 -6.30 -9.85 2.28 2.39 3.60 3.12 4.05 Interest Cover 0.81 -0.11 3.94 0.45 -2.08 -1.15 -1.09 0.57 1.24 0.86

Top Investors:

thermo capital private limited

dalal & broacha stock broking pvt.ltd

Annual Reports:

News Update:

Lyka Labs gets Indian patent for Pregabalin Gel 8%
8th Apr 2025, 14:42 PM

With this patent, the company strengthens its intellectual property portfolio and reaffirms its vision to be at the forefront of innovative pharmaceutical solutions
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback